Quince Therapeutics Inc (QNCX)
0.95
+0.03
(+3.26%)
USD |
NASDAQ |
May 10, 16:00
0.9582
+0.01
(+0.86%)
After-Hours: 20:00
Quince Therapeutics Total Liabilities (Quarterly): 82.82M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.82M |
| September 30, 2023 | 2.253M |
| June 30, 2023 | 1.952M |
| March 31, 2023 | 3.115M |
| December 31, 2022 | 3.317M |
| September 30, 2022 | 5.246M |
| June 30, 2022 | 6.331M |
| March 31, 2022 | 9.75M |
| December 31, 2021 | 14.64M |
| September 30, 2021 | 14.76M |
| June 30, 2021 | 19.31M |
| Date | Value |
|---|---|
| March 31, 2021 | 18.04M |
| December 31, 2020 | 17.20M |
| September 30, 2020 | 16.65M |
| June 30, 2020 | 13.74M |
| March 31, 2020 | 13.16M |
| December 31, 2019 | 8.892M |
| September 30, 2019 | 6.127M |
| June 30, 2019 | 7.025M |
| March 31, 2019 | 108.62M |
| December 31, 2018 | 105.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.952M
Minimum
Jun 2023
82.82M
Maximum
Dec 2023
13.91M
Average
9.75M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 167.90M |
| Shareholders Equity (Quarterly) | 85.08M |